Cargando…
Comment on “Using Human ‘Experiments of Nature’ to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors”
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182455/ https://www.ncbi.nlm.nih.gov/pubmed/30066314 http://dx.doi.org/10.1007/s40264-018-0702-y |
_version_ | 1783362568083996672 |
---|---|
author | Ward, Lucas D. Moffat, Graeme J. Yuan, Jing Nioi, Paul |
author_facet | Ward, Lucas D. Moffat, Graeme J. Yuan, Jing Nioi, Paul |
author_sort | Ward, Lucas D. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6182455 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-61824552018-10-22 Comment on “Using Human ‘Experiments of Nature’ to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors” Ward, Lucas D. Moffat, Graeme J. Yuan, Jing Nioi, Paul Drug Saf Letter to the Editor Springer International Publishing 2018-07-31 2018 /pmc/articles/PMC6182455/ /pubmed/30066314 http://dx.doi.org/10.1007/s40264-018-0702-y Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Letter to the Editor Ward, Lucas D. Moffat, Graeme J. Yuan, Jing Nioi, Paul Comment on “Using Human ‘Experiments of Nature’ to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors” |
title | Comment on “Using Human ‘Experiments of Nature’ to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors” |
title_full | Comment on “Using Human ‘Experiments of Nature’ to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors” |
title_fullStr | Comment on “Using Human ‘Experiments of Nature’ to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors” |
title_full_unstemmed | Comment on “Using Human ‘Experiments of Nature’ to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors” |
title_short | Comment on “Using Human ‘Experiments of Nature’ to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors” |
title_sort | comment on “using human ‘experiments of nature’ to predict drug safety issues: an example with pcsk9 inhibitors” |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182455/ https://www.ncbi.nlm.nih.gov/pubmed/30066314 http://dx.doi.org/10.1007/s40264-018-0702-y |
work_keys_str_mv | AT wardlucasd commentonusinghumanexperimentsofnaturetopredictdrugsafetyissuesanexamplewithpcsk9inhibitors AT moffatgraemej commentonusinghumanexperimentsofnaturetopredictdrugsafetyissuesanexamplewithpcsk9inhibitors AT yuanjing commentonusinghumanexperimentsofnaturetopredictdrugsafetyissuesanexamplewithpcsk9inhibitors AT nioipaul commentonusinghumanexperimentsofnaturetopredictdrugsafetyissuesanexamplewithpcsk9inhibitors |